Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
99 Another 8-week aerobic exercise intervention demonstrated an 11.92% and 45.45% increase in serum total osteocalcin and undercarboxylated osteocalcin levels, respectively, in the exercise group, and no dramatic changes were observed in the control group
More than just a consumer-friendly wearable, Osteoboost is an FDA-cleared medical device, designated a Breakthrough Device by the FDA and approved through the De Novo pathway
17 The follow-on patent applications and granted patents cover minor modifications
Updated May 6, 2024
US$ 24.62
US$ 20.94
US$ 28.55
US$ 27.27
